Ocugen Establishes Vaccine Scientific Advisory BoardLeading experts to evaluate the clinical and regulatory path to approval in the US market of COVAXIN™, a whole-virion inactivated COVID-19 vaccine - BioSpace Get link Facebook X Pinterest Email Other Apps December 24, 2020 Ocugen Establishes Vaccine Scientific Advisory BoardLeading experts to evaluate the clinical and regulatory path to approval in the US market of COVAXIN™, a whole-virion inactivated COVID-19 vaccine BioSpace Get link Facebook X Pinterest Email Other Apps Comments
Comments
Post a Comment